KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other financing activities (2016 - 2024)

West Pharmaceutical Services' Other financing activities history spans 14 years, with the latest figure at -$100000.0 for Q1 2024.

  • For Q1 2024, Other financing activities changed N/A year-over-year to -$100000.0; the TTM value through Mar 2024 reached -$100000.0, down 200.0%, while the annual FY2022 figure was $1.2 million, N/A changed from the prior year.
  • Other financing activities for Q1 2024 was -$100000.0 at West Pharmaceutical Services, roughly flat from -$100000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $2.3 million in Q4 2020 and bottomed at -$100000.0 in Q4 2022.
  • The 3-year median for Other financing activities is $200000.0 (2022), against an average of $680000.0.
  • The largest YoY upside for Other financing activities was 387.5% in 2020 against a maximum downside of 387.5% in 2020.
  • A 3-year view of Other financing activities shows it stood at $2.3 million in 2020, then plummeted by 104.35% to -$100000.0 in 2022, then changed by 0.0% to -$100000.0 in 2024.
  • Per Business Quant, the three most recent readings for WST's Other financing activities are -$100000.0 (Q1 2024), -$100000.0 (Q4 2022), and $200000.0 (Q2 2022).